We are delighted to receive this Horizon Europe grant, which is a further validation of both our scientific approach ...

Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279 Consecutive patients with head and ...

Head and neck cancer symptoms vary by tumor location, often presenting as a neck lump or voice changes. Smoking and HPV are major risk factors; cessation and vaccination are crucial preventive ...

In a recent analysis of data from more than a dozen studies, coffee and tea consumption was linked with lower risks of developing head and neck cancer, including cancers of the mouth and throat. The ...

In more recent decades, HPV has been shown as a risk factor for developing head and neck cancer. Head and neck cancer covers everything from throat, tongue, and tonsil cancer to laryngeal, mouth, and ...

“This collaboration underscores our belief in zanzalintinib’s potential to drive patient benefit in combination with immunotherapy or targeted therapy in HNSCC and RCC indications that have unmet ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

Key Points Interested in Corbus Pharmaceuticals Holdings, Inc.? Here are five stocks we like better. Corbus plans to start a ...